** Shares in Elekta EKTAb.ST fall about 4% after the Swedish radiation therapy equipment maker reported Q1 a slow start to the year, with order intake missing consensus
** It posted Q1 gross order intake of SEK 3,838 million ($403.33 million), down 8.4% year-on-year, and below the SEK 4,262 million seen by analysts in a company compiled consensus
** Jefferies says the orders are still in negative territory, hence it still questions Elekta's ability to sustain top-line momentum
** It says the start to the year was slow, the reiterated guidance is "vague"
** The broker notes the share is among the sector's weakest performers, reflecting rising operational challenges (U.S., China), tariff uncertainties, a weak start to 2025/2026 and CEO change
($1 = 9.5157 Swedish crowns)
(Reporting by Marta Frąckowiak)
((marta.frackowiak@thomsonreuters.com))